BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behaeghe O, Mangelschots E, De Vil B, Cras P. A systematic review comparing the diagnostic value of 14-3-3 protein in the cerebrospinal fluid, RT-QuIC and RT-QuIC on nasal brushing in sporadic Creutzfeldt-Jakob disease. Acta Neurol Belg 2018;118:395-403. [PMID: 30097826 DOI: 10.1007/s13760-018-0995-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Carrasco AE, Appleby BS, Cali I, Okhravi HR. Atypical Case of VV1 Creutzfeldt–Jakob Disease Subtype: Case Report. Front Neurol 2022;13:875370. [DOI: 10.3389/fneur.2022.875370] [Reference Citation Analysis]
2 Altuna M, Ruiz I, Zelaya MV, Mendioroz M. Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review. Medicina 2022;58:473. [DOI: 10.3390/medicina58040473] [Reference Citation Analysis]
3 Salehian R, Sina F, Moudi S. Creutzfeldt-Jakob disease: A case report. Caspian J Intern Med 2021;12:S359-62. [PMID: 34760082 DOI: 10.22088/cjim.12.0.359] [Reference Citation Analysis]
4 Mattsson-Carlgren N, Palmqvist S, Blennow K, Hansson O. Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies. Nat Commun 2020;11:6252. [PMID: 33288742 DOI: 10.1038/s41467-020-19957-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
5 Forloni G, Roiter I, Tagliavini F. Clinical trials of prion disease therapeutics. Current Opinion in Pharmacology 2019;44:53-60. [DOI: 10.1016/j.coph.2019.04.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
6 Laskowska E, Kuczyńska-Wiśnik D, Lipińska B. Proteomic analysis of protein homeostasis and aggregation. J Proteomics 2019;198:98-112. [PMID: 30529741 DOI: 10.1016/j.jprot.2018.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]